Cited by 134Inflammasome and immune disordersAdipokines, Inflammation, and Metabolic DiseasesAtherosclerosis and Cardiovascular Diseases

Inflammasomes: sensors of metabolic stresses for vascular inflammation

Open access
Yang, Xiao-feng·2013·Frontiers in Bioscience

Abstract

Metabolic syndrome is a major health issue in the western world. An elevated pro-inflammatory state is often found in patients with metabolic diseases such as type 2 diabetes and obesity. Atherosclerosis is one such clinical manifestation of pro-inflammatory state associated with the vasculature. The exact mechanism by which metabolic stress induces this pro-inflammatory status and promotes atherogenesis remained elusive until the discovery of the inflammasome protein complex. This complex is composed of pro-caspase-1 and pathogen sensors. Activation of inflammasome requires the transcriptional upregulation of inflammasome components and the post-translational assembly. Three models of inflammasome assembly have been proposed: 1) the ion channel model; 2) the reactive oxygen species (ROS) model; and 3) the lysosome model. In either case, inflammasome activation triggers the auto-activation of pro-caspase-1 into its mature form. Caspase-1, which was first discovered as the IL-1β converting enzyme, is known to be a major player in inflammatory and cell death pathways. Many endogenous metabolic ligands have been experimentally shown to activate inflammasome, and thus initiate the subsequent inflammation process. Further understanding of the distinct molecular mechanism by which metabolic ligands activates inflammasome could lead to developing novel therapeutic interventions for atherosclerosis and other clinical problems related to metabolic diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2741/4127

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. [41]Saha N Moldovan F Tardif G Pelletier JP Cloutier JM Martel-Pelletier J Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18 Arthritis Rheum 1999 42 1577 1587 10446854
  2. [78]Duewell P Kono H Rayner KJ Sirois CM Vladimer G Bauernfeind FG Abela GS Franchi L Nunez G Schnurr M Espevik T Lien E Fitzgerald KA Rock KL Moore KJ Wright SD Hornung V Latz E NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 2010 464 1357 1361 20428172 PMC2946640

Cited by

Sorted by citations

Authors
Yang, X.-F.
Affiliations
Cardiovascular Research Center (BR)
Corresponding author
Yang, Xiao-feng
Venue
Frontiers in Bioscience
Publisher
IMR Press
Published
2013
Volume
18
Issue
2
Pages
638
ISSN
  • 1093-4715 (ISSN-L)
  • 1093-9946
OpenAlex
W2971515230
Cited by
134
References
84
Citations by year
2026: 8 · 2025: 2 · 2024: 9 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 11 · 2017: 14 · 2016: 10 · 2015: 7 · 2014: 17 · 2013: 6
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Frontiers in bioscience (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (HL094451, HL-67033, HL77288, R01HL067033, R01HL117654, HL-108910, R01HL094451, R01HL108910, R01HL110764, R01HL077288, HL-110764)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
inflammasome, metabolic stress, vascular inflammation, atherosclerosis, metabolic syndrome, type 2 diabetes, obesity, IL-1β, reactive oxygen species, ion channel models, inflammasome assembly
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Carrier Proteins, Enzyme Activation, Humans, Inflammation, Stress, Physiological, Reactive Oxygen Species, Caspase 1, Atherosclerosis, Interleukin-1beta, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review